Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.85 | - | - |
| Perrigo Co. plc | 3 | 0 | 1 | 0 | €30.61 | €35.99 | 17.561% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €61.08 | €86.77 | 42.061% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €99.29 | €116.81 | 17.643% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €121.00 | €124.93 | 3.247% |
| AbbVie Inc. | 20 | 1 | 3 | 1 | €152.38 | €174.43 | 14.473% |
| Zoetis Inc. A | 21 | 1 | 4 | 1 | €149.32 | €200.06 | 33.979% |
| Biogen Inc. | 44 | 2 | 4 | 1 | €201.40 | €293.57 | 45.766% |
| Amgen Inc. | 21 | 0 | 3 | 0 | €256.75 | €294.28 | 14.619% |
| Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €368.10 | €382.71 | 3.968% |
| Eli Lilly Corp. | 51 | 0 | 7 | 0 | €732.70 | €766.92 | 4.670% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 7 | 1 | €834.80 | €957.22 | 14.665% |